Effects of Direct Tabletting Agents on Drug Release Kinetics and Swelling Behavior of Hydrophilic Matrix Tablets

Aims: This work focused on the effects of direct tabletting agents (DC-agents) (Microcel PH101®, Cellactose 80®, Ludipress LCE®, Pharmatose DCL11®) and hydroxypropyl-methylcellulose (HPMC) types (Methocel® K100LV, K15M, K100M) on release of Verapamil HCl from hydrophilic matrix tablets and swelling behaviors of these tablets. Material and Methods: Tablets were prepared by direct compression method. In vitro dissolution and swelling degree tests were performed on the tablets. The release mechanisms of drug were evaluated by using Korsmeyer-Peppas model. Results: While the increase in cellulose content of DC-agents contributed to the swelling of matrices and decreased the release rate of drug from the matrices, in contrast the increase in lactose content of DC-agents caused a faster hydration and erosion of the matrices and accelerated the release of drug. The increase in viscosity grade of HPMC resulted as a decrease in release rate of drug and Methocel K15M and K100M delayed the release of drug to the same extent. Drug release was mainly fitted to the non-Fickian transport mechanism and became diffusive by decreasing the R/F values of the matrices. Tablets containing Cellactose® 80 showed an equal contribution of diffusion and swelling with 3 types of HPMCs, according to their n values and R/F profiles. The FM1 formulation containing Microcel PH101® with Methocel K100LV and the reference product Isoptin®-KKH both showed a non-Fickian transport mechanism and they were found to be similar depending on the values of difference factor (f1 = 9.4) and similarity factor (f2 = 56.8). Conclusions: An extended release tablet formulation can be prepared as a matrix tablet by using a cellulose based DC-agent and a low viscosity grade HPMC polymer as an alternative to film coated tablets.

Effects of Direct Tabletting Agents on Drug Release Kinetics and Swelling Behavior of Hydrophilic Matrix Tablets

Aims: This work focused on the effects of direct tabletting agents (DC-agents) (Microcel PH101®, Cellactose 80®, Ludipress LCE®, Pharmatose DCL11®) and hydroxypropyl-methylcellulose (HPMC) types (Methocel® K100LV, K15M, K100M) on release of Verapamil HCl from hydrophilic matrix tablets and swelling behaviors of these tablets. Material and Methods: Tablets were prepared by direct compression method. In vitro dissolution and swelling degree tests were performed on the tablets. The release mechanisms of drug were evaluated by using Korsmeyer-Peppas model. Results: While the increase in cellulose content of DC-agents contributed to the swelling of matrices and decreased the release rate of drug from the matrices, in contrast the increase in lactose content of DC-agents caused a faster hydration and erosion of the matrices and accelerated the release of drug. The increase in viscosity grade of HPMC resulted as a decrease in release rate of drug and Methocel K15M and K100M delayed the release of drug to the same extent. Drug release was mainly fitted to the non-Fickian transport mechanism and became diffusive by decreasing the R/F values of the matrices. Tablets containing Cellactose® 80 showed an equal contribution of diffusion and swelling with 3 types of HPMCs, according to their n values and R/F profiles. The FM1 formulation containing Microcel PH101® with Methocel K100LV and the reference product Isoptin®-KKH both showed a non-Fickian transport mechanism and they were found to be similar depending on the values of difference factor (f1 = 9.4) and similarity factor (f2 = 56.8). Conclusions: An extended release tablet formulation can be prepared as a matrix tablet by using a cellulose based DC-agent and a low viscosity grade HPMC polymer as an alternative to film coated tablets.

___

  • Mahaguna V, Talbert RL, Peters JI, Adams S, Reynolds TD, Lam FYW, Williams III RO. Influence of hydroxypropyl methylcellulose polymer on in vitro and in vivo performance of controlled release tablets containing alprazolam. Eur. J. Pharm. Biopharm. 2003; 56: 461-468.
  • Sako K, Sawada T, Nakashima H, Yokohama S, Sonobe T. Influence of water soluble fillers in hydroxypropylmethylcellulose matrices on in vitro and in vivo drug release. J. Controlled Release. 2002; 81: 165-172.
  • Vueba ML, Batista de Carvalho LAE, Veiga F, Sousa JJ, Pina ME. Influence of cellulose ether polymers on ketoprofen release from hydrophilic matrix tablets. Eur. J. Pharm. Biopharm. 2004; 58: 51-59.
  • Jordan MP, Taylor J, Hindmarch P. Characterisation of hydroxypropylmethyl-cellulose hydrophilic matrices using multivariate analysis tecniques. Technical Data of Colorcon Limited, www.colorcon.com/pharma/post_articles/char_hpmc_multi_ anal.pdf England. Available from:
  • Huang YB, Tsai YH, Yang WC, Chang JS, Wu PC, Takayama K. Once-daily propranolol extended-release tablet dosage form: formulation design and in vitro/in vivo investigation. Eur. J. Pharm. Biopharm. 2004; 58: 607-614.
  • GE Peck, GJ Baley, VE McCurdy, GS Banker. Tablet formulation and design. Pharmaceutical Dosage Forms,Tablets (Eds. HA Lieberman, L Lachman, JB Schwartz) 2ndEd, Marcel Dekker, New York 1989, pp:109.
  • Ford JL, Rubinstein MH, Hogan JE. Formulation of sustained- release hydroxypropylmethylcellulose matrices. Int. J. Pharm. 1985; 24: 327-338. tablets using
  • Feely LC, Davis SS. Influence of surfactans on drug release from hydroxypropyl methylcellulose matrices. Int. J. Pharm. 1988; 41: 83-89.
  • Bettini R, Colombo P, Massimo G, Catellani PL, Vitali T. Swelling and drug release in hydrogel matrices: Polymer viscosity and matrix porosity effects. Eur. J. Pharm. Sci. 1994; 2: 213-219.
  • Reynolds TD, Dasbach TP. A study of polymer blending and polymer erosion of different viscosity grades of HPMC for hydrophilic matrix tablets. Dow Chemical Company. Midland. MI 48674. 1999.
  • Wan LSC, Heng PWS, Wongh LF. The effect of hydroxypropylmethylcellulose on water penetration into a matrix system. Int. J. Pharm. 1991; 73: 111-116.
  • Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. Int. J. Pharm. 1983; 15: 25-35.
  • Ritger PL, Peppas NA. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J. Controlled Release. 1987; 5: 37-42.
  • Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxpropylmethylcellulose (HPMC). Advanced Drug Delivery Reviews. 2001; 48: 139-157.
  • Colombo P, Bettini R, Santi P, Peppas NA. Swellable matrices for controlled drug delivery: Gel-layer behaviour, mechanisms and optimal performance. Reviews/research focus PSTT. 2000; 3: 198-204.
  • Hopfenberg HB, Hsu KC. Swelling-controlled, constant rate delivery systems. Polym. Eng. Sci. 1978; 18: 1186-1191.
  • Peppas NA, Sahlin JJ. A simple equation for the description of solute release. III. Coupling of diffusion and relaxation. Int. J. Pharm. 1989; 57: 169-172.
  • Moore JW, Flanner HH. Mathematical comparison of curves with an emphasis on in vitro dissolution profiles. Pharm. Tech. 1996; 20: 64-74.